News from CROI 2025
Researchers from the IMPAACT Network presented data during five poster presentations and one themed discussion at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI), held from 9 to 12 March 2025 in San Francisco, California, USA.
Presentations and posters from the IMPAACT Network are listed below. Digital copies of presentations and posters will be hyperlinked when available. For the full conference program, visit the CROI website.
Posters
Below are poster presentations and materials from the themed discussion given during CROI 2025.
IMPAACT 2010/VESTED
Wu D, Baltrusaitis K, Nematadzira T, Kaiyo-Utete M, Coletti A, McCarthy K, Krotje C, Chinula L, Lockman S, Stranix-Chibanda L
IMPAACT P1026s
Population PK and CYP3A Inhibition Capacity of Ritonavir in Pregnancy: A Model-Based Meta-Analysis
Algharbi SA, Liyanage MJ, Mirochnick M, Best BM, Barr E, Stek A, Brooks KM, Burchett S, Powis KM, Cressey T, Capparelli EV, Momper JD
PROMISE P1084s
Insulin-like Growth Factors and Stunting in Infants Exposed to HIV and Uninfected (Themed Discussion Slides)
Kakayi BC, Baltrusaitis K, DeMarrais P, Rexroad V, Nakabiito C, Stranix-Chibanda L, Fowler MG, Stanley TL
IMPAACT 2036/CRAYON
Safety and pharmacokinetics of long-acting cabotegravir and rilpivirine in children between 20-40 kg
Archary M, Pinto J, Capparelli E, Acosta EP, Cheung SYA, Kakuda TN, Townley EM, Moye J, Milligan R, Scheckter R, Masheto G, Ounchanum P, Aurpibul L, Fairlie L, CRAYON Study Team
IMPAACT 2023
PK and Safety of Chronic Dolutegravir Administration in Neonates Exposed to HIV-1 (IMPAACT 2023)